跳至主要内容
临床试验/NCT02803073
NCT02803073撤回2 期

Effect of Testosterone Replacement on Exercise Capacity in Hypogonadal Men After A Recent Myocardial Infarction.

Texas Tech University Health Sciences Center1 个研究点 分布在 1 个国家开始时间: 2016年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Metabolic Equivalent

研究概览

简要总结

The purpose of this study is to determine the effects of testosterone replacement in hypogonadal men on exercise tolerance and cardiac rehabilitation after an acute myocardial infarction.

详细描述

Testosterone deficiency can decrease muscle strength. The researchers will replace testosterone in hypogonadal men undergoing rehabilitation exercises after heart attack.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • All men status-post Myocardial Infarction or Non-ST Elevation-Acute Coronary Syndrome within the last 3-8 weeks enrolling in the cardiac rehabilitation program at Mission Fitness-Medical Center Hospital.
  • Baseline free testosterone levels less than age-specific normal values.
  • Males 18 years and older

排除标准

  • Prostate Specific Antigen greater than age based, ethnic-specific cut points (see Appendix), history of metastatic prostate cancer or symptoms suggestive of severe Benign Prostatic Enlargement.
  • Current use of testosterone, clomiphene or over the counter testosterone boosters
  • Patients initiating cardiac rehabilitation 8+ weeks after MI or Non-ST Elevation-Acute Coronary Syndrome
  • Congestive heart failure, New York Heart Association class IV
  • Life expectancy less than 1 year,
  • Baseline hematocrit of >50%
  • Allergic reactions to testosterone or testosterone vehicle (i.e. cotton seed oil, etc.)
  • Physical inability to participate in rehabilitation program (examples: severe claudication, massive obesity, etc.)
  • Participation in any other concurrent clinical trial, use of an investigational agent or therapeutic regimen within 30 days of study
  • Patients formerly diagnosed with obstructive sleep apnea.
  • Patients using opiate analgesics
  • Patients with aspartate aminotransferase/alanine aminotransferase values more than 3 times normal
  • History of Deep venous thrombosis

研究组 & 干预措施

Testosterone Replacement

Experimental

The experimental group will receive 0.5 ml (100 mg) testosterone cypionate Intramuscular injections each week for 11 weeks.

干预措施: Testosterone (Drug)

Control

Placebo Comparator

Patients in the control group will receive intramuscular normal saline injections.

干预措施: Normal Saline (Drug)

结局指标

主要结局

Metabolic Equivalent

时间窗: 12 weeks

次要结局

  • 6 minute walk test(12 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验